Results showed TMAO inhibited autophagy and activated NLRP3 inflammasome, which were reversed by ATG16L1 or NLRP3 knockdown, indicating a mechanistic link in IBD pathogenesis. This evidence concerns the gene NLRP3 and inflammatory bowel disease.